Pre-earnings options volume in Viking Therapeutics (VKTX) is 1.1x normal with calls leading puts 8:5. Implied volatility suggests the market is anticipating a move near 8.5%, or $5.15, after results are released. Median move over the past eight quarters is 7.6%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VKTX:
- Is VKTX a Buy, Before Earnings?
- Viking Therapeutics reports data from Phase 1b clinical trial of VK0214
- Viking Therapeutics call volume above normal and directionally bullish
- Viking’s oral VK2735 a potential candidate for OTC status, says Oppenheimer
- Unusually active option classes on open September 20th